Dr. Lingjun Li's lab focuses on advancing our understanding and diagnosis of Alzheimer's disease (AD) through innovative technologies. The research aims to discover and validate biomarkers associated with AD using advanced mass spectrometry techniques and molecular mapping strategies. By doing this, the lab hopes to shed light on the progression of AD and improve early diagnostic capabilities for this devastating disease.